Artificial intelligence: the patient bears the risk
Special for Manager Magazin (MM) and for Harvard Business Manager (HBM) – February 2020
In cooperation with representatives from Capgemini Germany, Roche Diagnostics GmbH, Paul Hartmann AG, Ottobock, PTC, Pegasystems and Thescon, a special is being created for Manager Magazin (MM) and for Harvard Business Manager (HBM) on the subject of ‘Digitization of the Life Sciences Industry ‘.
Dr. Claus Breer and Ingo Baumann from Thescon compiled the outlook on Artificial Intelligence in Regulated Industry (see pdf).
Artificial intelligence is the promise of better decisions, faster processes and savings in personnel costs. However, patients pay the ultimate price for mistakes. How does the life sciences industry deal with this risk?
The special ‘Digitization of the Life Sciences Industry’ can be found here.
We wish all readers an informative read.